UbiVac
Blood & Organ Banks · Oregon, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
18183 SW Boones Ferry Rd, Portland, Oreg...Phone Number
(503) 292-4066Website
www.ubivac.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
1
2
2
1
1
1
About UbiVac
UbiVac is a clinical stage immunotherapy and cancer target discovery company pioneering the world's first Dark Genome-derived cancer immunotherapy. Their lead agent, DPV-001, utilizes non-mutated shared alternative cancer neoantigens to stimulate immune responses in patients with advanced cancers. UbiVac targets patients with adenocarcinoma or squamous cell cancers, aiming to improve treatment outcomes through innovative vaccine technology and collaborations with leading research institutes. The company is positioned as a leader in non-canonical target discovery, developing next-generation cancer vaccines and therapies based on real-world immunogenicity.Explore more
UbiVac Org Chart
TT
Principal Investigator
GM
Process Development Associate
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is UbiVac your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Product Launch: Get notified when UbiVac launches new products
Funding: Get notified immidiatlly once UbiVac has new funding data
UbiVac, which may be a good buyer, showed buying intent in Masked Content Topic
Congratulate Masked Content for being promoted to Masked Content at UbiVac
Check out if UbiVac is spiking on competitors!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Earning: See what the market has to say on UbiVac recently announced quarterly report
Check if UbiVac has recently received funding, and reach out quickly before it becomes old news!
Click to see if UbiVac had a recent Job posting/layoffs
Website visits: Recent activity has been detected on your website
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Compare Similar Companies to UbiVac
Compare insights from companies similar to UbiVac, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
UbiVac is experiencing very low activity levels compared to other companies in the Healthcare Services sector.
What does this means?
UbiVac is drawing exceptional interest within the Healthcare Services industry, suggesting notable developments or strong market momentum, learn more about UbiVac.
UbiVac Tech Stack
A closer look at the technologies used by UbiVac
Top Blood & Organ Banks Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding UbiVac
Sign Up For FreeTo access detailed company insights
UbiVac is a clinical stage immunotherapy and cancer target discovery company pioneering the world's first Dark Genome-derived cancer immunotherapy. Their lead agent, DPV-001, utilizes non-mutated shared alternative cancer neoantigens to stimulate immune responses in patients with advanced cancers. UbiVac targets patients with adenocarcinoma or squa... Read More
